Integra Lifesciences (IART) Tops Q2 EPS by 4c

Integra Lifesciences (NASDAQ: IART) reported Q2 EPS of $0.68, $0.04 better than the analyst estimate of $0.64. Revenue for the quarter came in at $231.4 million versus the consensus estimate of $229.32 million.

For earnings history and earnings-related data on Integra Lifesciences (IART) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Bernstein SocGen on UnitedHealth Group (UNH): 'Expecting a strong 2Q driven by MA and potential for guidance raise'
• BTC Digital closes $7M private placement to build Georgia AI data center